Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer
International Journal of Molecular Sciences · 17.03.2023 · 24 (6) · 5748
DOI: 10.3390/ijms24065748 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.03.2023. Verfasst von Divakar Dahiya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wexham Park Hospital, Wexham Street, Slough SL2 4HL, UK. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Gastrointestinal Microbiome, Probiotics, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The gut microbiota is composed of several microbial strains with diverse and variable compositions in both healthy and sick people. An undisturbed gut microbiota needs to be sustained in order to perform all physiological, metabolic, and immune functions in a normal way to prevent the development of diseases. This article has reviewed the published information on the issue of disruption of the balance of the gut microbiota. This disruption could be for many reasons, such as microbial infection in the gastrointestinal tract, food poisoning, diarrhoea, chemotherapy, malnutrition, lifestyle, and ageing. If this disruption is not restored to normal, it might cause dysbiosis. Eventually, a gut microbiota interrupted by dysbiosis might initiate several health issues, such as inflammation of the gastrointestinal tract, the induction of cancer, and the progression of a variety of diseases such as irritable bowel syndrome and inflammatory bowel disease. This review concluded that biotherapy is a natural way of using probiotic products, whether in form of food, beverages, or supplements, to restore the gut microbiota disrupted by dysbiosis. Metabolites secreted by the ingested probiotics help to relieve gastrointestinal tract inflammation and can avoid the induction of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wexham Park Hospital, Wexham Street, Slough SL2 4HL, UK.
- Biomedical Sciences Research Institute, Ulster University, Coleraine BT52 1SA, UK.
ORCID-Profile: Poonam Singh Nigam
Zitieren
APA
Dahiya, D., & Nigam, P. S. (2023). Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer. International Journal of Molecular Sciences, 24(6), 5748. https://doi.org/10.3390/ijms24065748
Vancouver
Dahiya D, Nigam PS. Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer. International Journal of Molecular Sciences. 2023;24(6):5748. doi:10.3390/ijms24065748
BibTeX
@article{Dahiya2023,
author = {Dahiya, Divakar and Nigam, Poonam Singh},
title = {Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5748},
doi = {10.3390/ijms24065748}
}
EUVIMED